US Stock MarketDetailed Quotes

BGLC BioNexus Gene Lab

Watchlist
  • 0.229
  • -0.034-12.80%
Close Dec 20 16:00 ET
  • 0.244
  • +0.015+6.47%
Post 20:01 ET
4.11MMarket Cap19.08P/E (TTM)

BioNexus Gene Lab Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
3.00%2.63M
-23.07%1.97M
0.20%2.38M
-10.60%9.77M
-19.95%2.27M
-0.83%2.55M
3.29%2.57M
-21.52%2.38M
-18.21%10.93M
-12.50%2.84M
Operating revenue
3.00%2.63M
-23.07%1.97M
0.20%2.38M
-10.60%9.77M
-19.95%2.27M
-0.83%2.55M
3.29%2.57M
-21.52%2.38M
-18.21%10.93M
-12.50%2.84M
Cost of revenue
4.75%2.3M
-24.30%1.69M
0.42%2.02M
-12.70%8.44M
-19.75%2.01M
-3.35%2.2M
0.27%2.23M
-24.86%2.01M
-12.85%9.67M
-9.67%2.5M
Gross profit
-7.84%326.54K
-15.01%288.72K
-1.05%365.03K
5.60%1.33M
-21.42%266.56K
18.31%354.33K
28.69%339.71K
3.53%368.9K
-44.46%1.26M
-28.91%339.23K
Operating expense
-42.27%1.66M
-95.17%29.55K
5.85%444.06K
153.07%3.92M
-98.09%8.8K
690.44%2.88M
52.24%611.91K
30.43%419.53K
28.00%1.55M
67.30%461.92K
Selling and administrative expenses
-30.90%2.13M
-5.88%759.66K
20.31%645.91K
154.94%4.41M
-103.48%-16.96K
635.90%3.08M
77.46%807.08K
45.87%536.87K
35.37%1.73M
166.84%487.86K
-General and administrative expense
-30.90%2.13M
-5.88%759.66K
20.31%645.91K
154.94%4.41M
-103.48%-16.96K
635.90%3.08M
77.46%807.08K
45.87%536.87K
35.37%1.73M
166.84%487.86K
Other operating expenses
-133.60%-465.53K
-274.10%-730.11K
-72.01%-201.85K
-171.10%-486.04K
199.28%25.76K
-268.29%-199.28K
-269.29%-195.16K
-152.93%-117.34K
-169.63%-179.28K
-127.81%-25.94K
Operating profit
47.10%-1.34M
195.21%259.17K
-56.09%-79.03K
-790.73%-2.59M
310.09%257.75K
-3,777.19%-2.53M
-97.30%-272.2K
-245.95%-50.63K
-127.58%-291.18K
-161.02%-122.69K
Net non-operating interest income expense
-45.41%-6.19K
-47.27%-4.48K
-90.63%-4.66K
-11.62%-13.93K
12.16%-4.18K
-105.55%-4.26K
-31.18%-3.04K
26.49%-2.45K
3.81%-12.48K
-19.47%-4.76K
Non-operating interest expense
45.41%6.19K
47.27%4.48K
90.63%4.66K
11.62%13.93K
-12.16%4.18K
105.55%4.26K
31.18%3.04K
-26.49%2.45K
-3.81%12.48K
19.47%4.76K
Other net income (expense)
Income before tax
46.94%-1.34M
192.53%254.69K
-57.68%-83.69K
-758.71%-2.61M
298.96%253.57K
-3,664.13%-2.53M
-96.20%-275.24K
-269.22%-53.08K
-129.12%-303.66K
-164.67%-127.45K
Income tax
-97.97%1.56K
447.62%55.58K
25.50%20.07K
-58.85%21.53K
-285.96%-54.89K
655.57%76.42K
-886.43%-15.99K
11.83%15.99K
-82.04%52.31K
-72.63%29.52K
Net income
48.44%-1.35M
176.80%199.1K
-50.23%-103.76K
-638.57%-2.63M
296.51%308.46K
-3,271.00%-2.61M
-86.97%-259.25K
-504.70%-69.07K
-147.36%-355.97K
-275.89%-156.97K
Net income continuous Operations
48.44%-1.35M
176.80%199.1K
-50.23%-103.76K
-638.57%-2.63M
296.51%308.46K
-3,271.00%-2.61M
-86.97%-259.25K
-504.70%-69.07K
-147.36%-355.97K
-275.89%-156.97K
Minority interest income
Net income attributable to the parent company
48.44%-1.35M
176.80%199.1K
-50.23%-103.76K
-638.57%-2.63M
296.51%308.46K
-3,271.00%-2.61M
-86.97%-259.25K
-504.70%-69.07K
-147.36%-355.97K
-275.89%-156.97K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
48.44%-1.35M
176.80%199.1K
-50.23%-103.76K
-638.57%-2.63M
296.51%308.46K
-3,271.00%-2.61M
-86.97%-259.25K
-504.70%-69.07K
-147.36%-355.97K
-275.89%-156.97K
Basic earnings per share
51.86%-0.0749
162.93%0.0113
-157.14%-0.018
-297.83%-0.183
129.86%0.0096
-2,809.03%-0.1555
-86.17%-0.0179
-685.28%-0.007
-195.83%-0.046
-2,137.34%-0.0322
Diluted earnings per share
51.86%-0.0749
162.93%0.0113
-157.14%-0.018
-297.83%-0.183
129.86%0.0096
-2,809.03%-0.1555
-86.17%-0.0179
-685.28%-0.007
-195.83%-0.046
-2,137.34%-0.0322
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 3.00%2.63M-23.07%1.97M0.20%2.38M-10.60%9.77M-19.95%2.27M-0.83%2.55M3.29%2.57M-21.52%2.38M-18.21%10.93M-12.50%2.84M
Operating revenue 3.00%2.63M-23.07%1.97M0.20%2.38M-10.60%9.77M-19.95%2.27M-0.83%2.55M3.29%2.57M-21.52%2.38M-18.21%10.93M-12.50%2.84M
Cost of revenue 4.75%2.3M-24.30%1.69M0.42%2.02M-12.70%8.44M-19.75%2.01M-3.35%2.2M0.27%2.23M-24.86%2.01M-12.85%9.67M-9.67%2.5M
Gross profit -7.84%326.54K-15.01%288.72K-1.05%365.03K5.60%1.33M-21.42%266.56K18.31%354.33K28.69%339.71K3.53%368.9K-44.46%1.26M-28.91%339.23K
Operating expense -42.27%1.66M-95.17%29.55K5.85%444.06K153.07%3.92M-98.09%8.8K690.44%2.88M52.24%611.91K30.43%419.53K28.00%1.55M67.30%461.92K
Selling and administrative expenses -30.90%2.13M-5.88%759.66K20.31%645.91K154.94%4.41M-103.48%-16.96K635.90%3.08M77.46%807.08K45.87%536.87K35.37%1.73M166.84%487.86K
-General and administrative expense -30.90%2.13M-5.88%759.66K20.31%645.91K154.94%4.41M-103.48%-16.96K635.90%3.08M77.46%807.08K45.87%536.87K35.37%1.73M166.84%487.86K
Other operating expenses -133.60%-465.53K-274.10%-730.11K-72.01%-201.85K-171.10%-486.04K199.28%25.76K-268.29%-199.28K-269.29%-195.16K-152.93%-117.34K-169.63%-179.28K-127.81%-25.94K
Operating profit 47.10%-1.34M195.21%259.17K-56.09%-79.03K-790.73%-2.59M310.09%257.75K-3,777.19%-2.53M-97.30%-272.2K-245.95%-50.63K-127.58%-291.18K-161.02%-122.69K
Net non-operating interest income expense -45.41%-6.19K-47.27%-4.48K-90.63%-4.66K-11.62%-13.93K12.16%-4.18K-105.55%-4.26K-31.18%-3.04K26.49%-2.45K3.81%-12.48K-19.47%-4.76K
Non-operating interest expense 45.41%6.19K47.27%4.48K90.63%4.66K11.62%13.93K-12.16%4.18K105.55%4.26K31.18%3.04K-26.49%2.45K-3.81%12.48K19.47%4.76K
Other net income (expense)
Income before tax 46.94%-1.34M192.53%254.69K-57.68%-83.69K-758.71%-2.61M298.96%253.57K-3,664.13%-2.53M-96.20%-275.24K-269.22%-53.08K-129.12%-303.66K-164.67%-127.45K
Income tax -97.97%1.56K447.62%55.58K25.50%20.07K-58.85%21.53K-285.96%-54.89K655.57%76.42K-886.43%-15.99K11.83%15.99K-82.04%52.31K-72.63%29.52K
Net income 48.44%-1.35M176.80%199.1K-50.23%-103.76K-638.57%-2.63M296.51%308.46K-3,271.00%-2.61M-86.97%-259.25K-504.70%-69.07K-147.36%-355.97K-275.89%-156.97K
Net income continuous Operations 48.44%-1.35M176.80%199.1K-50.23%-103.76K-638.57%-2.63M296.51%308.46K-3,271.00%-2.61M-86.97%-259.25K-504.70%-69.07K-147.36%-355.97K-275.89%-156.97K
Minority interest income
Net income attributable to the parent company 48.44%-1.35M176.80%199.1K-50.23%-103.76K-638.57%-2.63M296.51%308.46K-3,271.00%-2.61M-86.97%-259.25K-504.70%-69.07K-147.36%-355.97K-275.89%-156.97K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 48.44%-1.35M176.80%199.1K-50.23%-103.76K-638.57%-2.63M296.51%308.46K-3,271.00%-2.61M-86.97%-259.25K-504.70%-69.07K-147.36%-355.97K-275.89%-156.97K
Basic earnings per share 51.86%-0.0749162.93%0.0113-157.14%-0.018-297.83%-0.183129.86%0.0096-2,809.03%-0.1555-86.17%-0.0179-685.28%-0.007-195.83%-0.046-2,137.34%-0.0322
Diluted earnings per share 51.86%-0.0749162.93%0.0113-157.14%-0.018-297.83%-0.183129.86%0.0096-2,809.03%-0.1555-86.17%-0.0179-685.28%-0.007-195.83%-0.046-2,137.34%-0.0322
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.